Elite Pharmaceuticals Inc (ELTP)
0.5177
-0.06
(-9.98%)
USD |
OTCM |
Nov 14, 16:00
Elite Pharmaceuticals Total Return Level: 0.5177 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 0.5177 |
November 13, 2024 | 0.5751 |
November 12, 2024 | 0.5601 |
November 11, 2024 | 0.541 |
November 08, 2024 | 0.5098 |
November 07, 2024 | 0.4999 |
November 06, 2024 | 0.515 |
November 05, 2024 | 0.5098 |
November 04, 2024 | 0.5101 |
November 01, 2024 | 0.5013 |
October 31, 2024 | 0.443 |
October 30, 2024 | 0.435 |
October 29, 2024 | 0.51 |
October 28, 2024 | 0.569 |
October 25, 2024 | 0.5401 |
October 24, 2024 | 0.5755 |
October 23, 2024 | 0.4702 |
October 22, 2024 | 0.60 |
October 21, 2024 | 0.705 |
October 18, 2024 | 0.585 |
October 17, 2024 | 0.50 |
October 16, 2024 | 0.485 |
October 15, 2024 | 0.4406 |
October 14, 2024 | 0.418 |
October 11, 2024 | 0.4347 |
Date | Value |
---|---|
October 10, 2024 | 0.4064 |
October 09, 2024 | 0.3999 |
October 08, 2024 | 0.4033 |
October 07, 2024 | 0.3985 |
October 04, 2024 | 0.3917 |
October 03, 2024 | 0.3901 |
October 02, 2024 | 0.4198 |
October 01, 2024 | 0.3879 |
September 30, 2024 | 0.388 |
September 27, 2024 | 0.39 |
September 26, 2024 | 0.389 |
September 25, 2024 | 0.388 |
September 24, 2024 | 0.3786 |
September 23, 2024 | 0.3745 |
September 20, 2024 | 0.373 |
September 19, 2024 | 0.3889 |
September 18, 2024 | 0.3875 |
September 17, 2024 | 0.3825 |
September 16, 2024 | 0.3898 |
September 13, 2024 | 0.3601 |
September 12, 2024 | 0.402 |
September 11, 2024 | 0.3929 |
September 10, 2024 | 0.3548 |
September 09, 2024 | 0.3399 |
September 06, 2024 | 0.3135 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.0285
Minimum
Dec 29 2022
0.705
Maximum
Oct 21 2024
0.0889
Average
0.0578
Median
Jan 29 2021
Total Return Level Benchmarks
Biomarin Pharmaceutical Inc | 65.60 |
BioCardia Inc | 2.015 |
Zevra Therapeutics Inc | 9.03 |
Verrica Pharmaceuticals Inc | 0.8633 |
Terns Pharmaceuticals Inc | 6.55 |